CARsgen® U.S. Clinical Holds Lifted by FDA

SHANGHAI,Nov. 1,2024-- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK),a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors,

Home Previous 168 169 170 171 172 173 174 Next Tail

10 Items Per Page (Page 171 / 535) Total 5347 Items

©copyright2009-2020 British Weekly      Contact Us   SiteMap